GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 1 filers reported holding GALERA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $50,008 | -3.8% | 357,192 | -0.1% | 0.00% | – |
Q4 2023 | $51,999 | -19.9% | 357,622 | -3.5% | 0.00% | – |
Q3 2023 | $64,898 | -94.5% | 370,643 | -1.1% | 0.00% | – |
Q2 2023 | $1,169,341 | +43.0% | 374,789 | +17.3% | 0.00% | – |
Q1 2023 | $817,971 | +84.6% | 319,520 | +7.5% | 0.00% | – |
Q4 2022 | $443,010 | -18.4% | 297,323 | -4.8% | 0.00% | – |
Q3 2022 | $543,000 | +32.4% | 312,230 | -0.8% | 0.00% | – |
Q2 2022 | $410,000 | -46.4% | 314,659 | -2.1% | 0.00% | – |
Q1 2022 | $765,000 | -3.2% | 321,292 | +86.8% | 0.00% | – |
Q4 2021 | $790,000 | -47.5% | 172,039 | -7.5% | 0.00% | – |
Q3 2021 | $1,505,000 | -17.4% | 185,910 | +0.4% | 0.00% | – |
Q2 2021 | $1,821,000 | -65.1% | 185,141 | -68.7% | 0.00% | – |
Q1 2021 | $5,218,000 | -5.0% | 591,727 | +10.2% | 0.00% | – |
Q4 2020 | $5,493,000 | +43.7% | 536,965 | +27.1% | 0.00% | – |
Q3 2020 | $3,822,000 | +34.8% | 422,640 | +6.4% | 0.00% | – |
Q2 2020 | $2,836,000 | +317.1% | 397,177 | +455.0% | 0.00% | – |
Q1 2020 | $680,000 | -23.6% | 71,557 | +5.8% | 0.00% | – |
Q4 2019 | $890,000 | – | 67,634 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 3,083,712 | $29,295,000 | 2.71% |
NEA Management Company, LLC | 4,362,986 | $41,448,000 | 2.17% |
Novo Holdings A/S | 3,409,021 | $32,386,000 | 2.16% |
SPHERA FUNDS MANAGEMENT LTD. | 475,677 | $4,519,000 | 0.56% |
RA Capital Management | 893,115 | $8,485,000 | 0.27% |
Rock Springs Capital Management LP | 500,000 | $4,750,000 | 0.20% |
Tekla Capital Management LLC | 416,666 | $3,958,000 | 0.18% |
Blackstone Inc. | 1,678,984 | $15,950,000 | 0.12% |
Perceptive Advisors | 325,000 | $3,088,000 | 0.08% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,309,500 | $12,440,000 | 0.04% |